ASH 2010 Conference Coverage

Analgesic Effects of Cannabis Is Different Between Men and Women

Pain response—sensitivity and tolerance—after use of active cannabis differs between men and women.

Poor Oral Health Associated With OPSCC Regardless of HPV Status

Despite a higher risk for HPV-negative orophayngeal squamous cell carcinoma (OPSCC), poor oral health appears to be associated with OPSCC regardless of HPV status.

Methylnaltrexone Linked to Improved Survival in Advanced Cancer

Treatment with methylnaltrexone was associated with improved overall survival in patients with advanced cancer.

Music Interventions Improve Cancer and Treatment Symptoms

Benefits of music-related interventions for patients with cancer range from a moderate-to-strong effect to a small reduction in symptoms for various effects of the disease and its treatment.

Novel Radiotracer Is Near Perfect in Detecting Sentinel Lymph Node in Breast Cancer

A novel sentinel lymph node (SLN) radiotracer, 99mTC-rituximab, demonstrated nearly 100% detection/success rate in SLN and metastasis in breast cancer.

MammaPrint Helps to Identify Which Patients Require Adjuvant Chemotherapy

The 70-gene signature test, in combination with standard clinical-pathologic criteria, may help clinicians decide whether patients with early stage breast cancer who are at high clinical risk require adjuvant chemotherapy.

Supportive Care Needs Assessed in Localized Cutaneous Melanoma

Patients with localized melanoma see their supportive care needs peak at their initial cancer diagnosis and if they experience disease recurrence.

Recently Discovered microRNA Controls Response to Oxaliplatin in Colorectal Cancer

Danish researchers identified a microRNA shown to predict whether a patient with colorectal cancer would be resistant to oxaliplatin treatment, a discovery that holds promise of improving both current treatment options and development of future treatment strategies.

Nurses Are Key to Referrals to Inpatient Integrative Medicine Services

Most clinicians support use of integrative services for hospitalized patients, and most referrals for these services are nurse-driven, a NIH-funded study conducted at a large tertiary care facility has shown.

Daratumumab Combo Improves PFS in Relapsed/Refractory Myeloma

Daratumumab plus bortezomib and dexamethasone improves progression-free survival in multiple myeloma.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs